Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine. - Wikidata - wikimedia - TriplyDB

Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine.

Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine.

http://www.wikidata.org/entity/Q37522597

about

Traditional Chinese Medicine for Refractory Nephrotic Syndrome: Strategies and Promising Treatments.Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature.

P2860

Q55005671-9D9AF799-568D-427C-BB0C-13B66961FAE3 Q55043715-39A4589B-C195-4A78-B434-78AB88152A87

P2860

Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine.

http://www.wikidata.org/entity/Q37522597

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tacrolimus confers lower acute ...... ival compared to cyclosporine.

@en

Tacrolimus confers lower acute ...... ival compared to cyclosporine.

@nl

type

label

Tacrolimus confers lower acute ...... ival compared to cyclosporine.

@en

Tacrolimus confers lower acute ...... ival compared to cyclosporine.

@nl

prefLabel

Tacrolimus confers lower acute ...... ival compared to cyclosporine.

@en

Tacrolimus confers lower acute ...... ival compared to cyclosporine.

@nl

P1433

Q37522597-ED4BD439-9E8A-4B45-B638-D8B7EF2DA518

P1476

Q37522597-EF426B36-9BAB-4DFA-96B3-01866771A357

P2093

Q37522597-314BB152-0790-4DD0-8C19-F7AB02793082

Q37522597-3ED8D759-0F87-4288-BCEB-E8429EE35944

Q37522597-65A57578-A347-4CCE-BA6A-C94D7F234EE6

Q37522597-9927362C-A9C8-4EDD-885E-790A52854A7E

Q37522597-C919BCCD-9004-43B3-8BAE-43DF97CD254E

P2860

Q37522597-13F2D230-7767-44A0-9DC6-57812858BE4B

Q37522597-232453F2-2D5F-4150-AA61-D64A8DA2D464

Q37522597-33F329B7-4C22-48E0-82E3-17A3C73C1547

Q37522597-7A97F48E-D1D3-4ED0-82EA-A41305C90749

Q37522597-8814D051-FA45-4F5D-9FB9-A7FC9DABED1C

Q37522597-B022B01A-1169-4B0D-9DCB-5D32A2BE8DFF

Q37522597-B05E5D93-BA55-4C3C-836E-4D45486C2372

Q37522597-B0F06DDE-9086-4D85-B33F-ACC866F5F68E

Q37522597-C2BDDC30-393C-489B-AAB7-5FCF55407E39

Q37522597-C9C88946-6B8C-4C38-949D-5470855A1A2A

P304

Q37522597-91135771-001B-463F-ABB8-DB2DE3C8C150

P31

Q37522597-E40E3F5A-8B40-4240-94E3-5D8FB1E993DB

P356

Q37522597-9A3DB4C9-8337-4780-8C5A-6515FC1D48D0

P433

Q37522597-6F9C3216-6566-49DF-A395-C8AF96F918B6

P478

Q37522597-6D3C3EDB-2443-4B8A-A900-178710A57A35

P577

Q37522597-83B1B9B8-538F-489F-8ED7-9C43BF25E26B

P698

Q37522597-EAAF91E8-B110-421C-A9F5-70B8F07348F0

P932

Q37522597-6E81E9C4-FF93-4ADB-A783-D824A815E148

P356

P1433

World journal of transplantation

P1476

Tacrolimus confers lower acute ...... ival compared to cyclosporine.

@en

P2093

David Taber

http://www.w3.org/2001/XMLSchema#string

Mahmoud Kamel

http://www.w3.org/2001/XMLSchema#string

Manish Kadian

http://www.w3.org/2001/XMLSchema#string

Maria Aurora Posadas Salas

http://www.w3.org/2001/XMLSchema#string

Titte Srinivas

http://www.w3.org/2001/XMLSchema#string

P2860

Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.

Factors in older cadaveric organ donors impacting on renal allograft outcome.

Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients.

Calcineurin-inhibitors in renal transplantation. Too precious to be abandoned.

Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials.

A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index.

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.

Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study.

Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity.

Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.

P304

697-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5500/WJT.V6.I4.697

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28058220

http://www.w3.org/2001/XMLSchema#string

P932

5175228

http://www.w3.org/2001/XMLSchema#string